Results 151 to 160 of about 17,702 (177)

Minocycline is a promising candidate as a combination therapy with caspofungin for drug-resistant Candida

Frontiers in Cellular and Infection Microbiology
Kazuhiro Itoh, Kazuhiro Itoh, Hiroshi Tsutani, Yasuhiko Mitsuke, Hiromichi Iwasaki   +4 more
doaj   +1 more source

Antifungal Susceptibility of Rare Yeasts Causing Vulvovaginal Candidiasis in the Acidic Vaginal Environment. [PDF]

Infect Drug Resist
Liu F, Sun Y, Zhao R, Zhang L, Deng S.
europepmc   +1 more source

A Cationic Supramolecule With Potent Antifungal Activity, Single-Species Selectivity, and Strong Synergy With Echinocandins. [PDF]

Adv Sci (Weinh)
Dai T, Chen AX, Chow EWL, Pang LM, Li J, Verma CS, Oehlers SH, Wang Y, Li N.   +8 more
europepmc   +1 more source

Literature review and case report on the use of rezafungin for spondylodiscitis in an outpatient parenteral antimicrobial therapy (OPAT) setting. [PDF]

J Bone Jt Infect
Richards AJ, Asif A, Ivan M, Lillie PJ, Barlow G, Walsh C.   +5 more
europepmc   +1 more source

A US Hospital-Perspective Decision-Analytic Model of Once-Weekly Rezafungin Versus Daily Echinocandin Therapy in Hospitalized Adults With Candidemia or Invasive Candidiasis: Potential Cost Savings From Earlier Discharge. [PDF]

Open Forum Infect Dis
Lodise TP, Patel N.
europepmc   +1 more source

Epidemiology, Antifungal Susceptibility, and in-Hospital Mortality of Candidemia in a Tertiary Hospital of China: A 10-Year Retrospective Analysis. [PDF]

Infect Drug Resist
Gu M, Zhu C, Xia W, Ni F, Jin F, Huang Y, Wang J.   +6 more
europepmc   +1 more source

Caspofungin Reshapes the Extracellular Vesicles Metabolome of <i>Candidozyma</i> (<i>Candida</i>) <i>auris</i>, Altering Amino Acid and Nucleotide Metabolism. [PDF]

J Fungi (Basel)
Alves V, Mulholland CV, Zamith-Miranda D, Frases S, Berney M, Nosanchuk JD.   +5 more
europepmc   +1 more source

The pharmacology and clinical use of caspofungin

Expert Opinion on Drug Metabolism and Toxicology, 2007
Caspofungin was the first echinocandin to be licensed for the treatment of invasive fungal infections. Caspofungin has in vitro and in vivo activity against Candida spp.
William Hope, Shmuel Shoham
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Population Pharmacokinetics of Caspofungin and Dose Simulations in Heart Transplant Recipients.

Antimicrobial Agents and Chemotherapy, 2022
Chunbo Chen, Xipei Wang, Fen Yao
exaly  

Population Pharmacokinetics of Caspofungin among Extracorporeal Membrane Oxygenation Patients during the Postoperative Period of Lung Transplantation.

Antimicrobial Agents and Chemotherapy, 2020
Chen Wang, Pengmei Li, Zhu Zhang
exaly